{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=24&sponsor=Yale+University", "query": { "sponsor": "Yale University", "page": 24 }, "page_size": 10 }, "pagination": { "page": 24, "page_size": 10, "total_count": 1897, "total_pages": 190, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=25&sponsor=Yale+University&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=23&sponsor=Yale+University&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T05:25:04.220Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01652573", "title": "Calcitonin for Treating X-linked Hypophosphatemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypophosphatemic Rickets, X Linked Dominant" ], "interventions": [ { "name": "nasal salmon calcitonin", "type": "DRUG" }, { "name": "Saline Nasal Spray Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 21, "start_date": "2011-03", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2017-05-31", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01652573" }, { "nct_id": "NCT02152670", "title": "Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cocaine Dependence" ], "interventions": [ { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Alpha Methyl Para Tyrosine (AMPT)", "type": "DRUG" }, { "name": "[11C]PHNO", "type": "OTHER" }, { "name": "[11C]raclopride", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 1, "start_date": "2014-05", "completion_date": "2014-06-09", "has_results": true, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02152670" }, { "nct_id": "NCT03918356", "title": "Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Idiopathic Inflammatory Myopathies" ], "interventions": [ { "name": "electrical impedance myography", "type": "DEVICE" }, { "name": "healthy control group", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 5, "start_date": "2019-06-01", "completion_date": "2021-05-30", "has_results": false, "last_update_posted_date": "2021-09-05", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03918356" }, { "nct_id": "NCT02206945", "title": "Neurofeedback for Obsessive-Compulsive Disorder (OCD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obsessive-Compulsive Disorder" ], "interventions": [ { "name": "neurofeedback", "type": "BEHAVIORAL" }, { "name": "control feedback", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2015-07", "completion_date": "2021-11", "has_results": false, "last_update_posted_date": "2022-02-11", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02206945" }, { "nct_id": "NCT00969696", "title": "Galantamine Effects on Cognitive Function in Marijuana Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Memory" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Galantamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 29, "start_date": "2009-08", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2012-07-25", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00969696" }, { "nct_id": "NCT01908686", "title": "Pivotal Response Treatment for Children With Autism Spectrum Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autism Spectrum Disorders" ], "interventions": [ { "name": "Pivotal Response Training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "4 Years to 35 Years" }, "enrollment_count": 40, "start_date": "2012-05", "completion_date": "2020-03-01", "has_results": false, "last_update_posted_date": "2020-08-14", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01908686" }, { "nct_id": "NCT07223983", "title": "Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alcohol Use Disorder", "Weight Loss", "Bariatric Surgery Patients" ], "interventions": [ { "name": "Semaglutide 1.0 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2026-03-26", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223983" }, { "nct_id": "NCT03446651", "title": "Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Lysine Chloride", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2018-07-12", "completion_date": "2022-09-07", "has_results": true, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03446651" }, { "nct_id": "NCT07332442", "title": "Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sleep Apnea", "Obstructive Sleep Apnea" ], "interventions": [ { "name": "Eszopiclone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2026-05-18", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "North Haven, Connecticut", "locations": [ { "city": "North Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT07332442" }, { "nct_id": "NCT02110641", "title": "Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Weight Loss" ], "interventions": [ { "name": "Weight Loss Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 51, "start_date": "2013-11", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2023-02-21", "last_synced_at": "2026-10-20T05:25:04.220Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02110641" } ] }